Alessandra Manes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alessandra Manes has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Nazzareno Galiè
Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Italy , Bologna , Italy
17 shared publications - Massimiliano Palazzini
University of Bologna, Department of Specialized, Diagnosticand Experimental Medicine – DIMES - Bologna/IT, Bologna, Italy
11 shared publications - Fabio Dardi
Cardiology Unit, IRCCS Azienda Ospedaliero-universitaria Di Bologna, Bologna, Italy
10 shared publications Massimiliano Palazzini
9 shared publicationsAngelo Branzi
4 shared publications- Daniele Guarino
Bologna University Hospital
4 shared publications
Latest Publications
- Open Access
- 15 May 2026
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 153, 106939
Pulmonary artery dilation in pulmonary arterial hypertension: haemodynamic determinants and association with sudden death
- 15 May 2026
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 153, 106939
Open AccessPulmonary artery dilation in pulmonary arterial hypertension: haemodynamic determinants and association with sudden death
- Open Access
- 28 February 2026
- Published by Elsevier in Vascular Pharmacology
- Vol. 163, 107590
2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective
- 28 February 2026
- Published by Elsevier in Vascular Pharmacology
- Vol. 163, 107590
Open Access2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective
- Open Access
- 7 November 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (44) , 4692-4695
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds
Pulmonary hypertension definition from the 2022 ESC/ERS Guidelines.
- 7 November 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (44) , 4692-4695
Open AccessConfirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds
Pulmonary hypertension definition from the 2022 ESC/ERS Guidelines.
- Open Access
- 12 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (10) , 3425
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors
Background: Pulmonary arterial hypertension (PAH) may complicate both portal hypertension (Po-PAH) and HIV infection (HIV-PAH). These two conditions, however, frequently coexist in the same patient (HIV/Po-PAH). We evaluated clinical, functional, hemodynamic characteristics and prognostic parameters of these three groups of patients. Methods: We included patients with Po-PAH, HIV-PAH and HIV/Po-PAH referred to a single center. We compared clinical, functional and hemodynamic parameters, severity of liver disease [Child–Turcotte–Pugh (CTP) and Model for End-stage Liver Disease-Na (MELD-Na) scores], CD4 count and highly active antiretroviral therapy (HAART) administration. Prognostic variables were identified through Cox-regression analysis. Results: Patients with Po-PAH (n = 128) were the oldest, patients with HIV-PAH (n = 41) had the worst hemodynamic profile and patients with HIV/Po-PAH (n = 35) had the best exercise capacity. Independent predictors of mortality were age and CTP score for Po-PAH, HAART administration for HIV-PAH, MELD-Na score and hepatic venous-portal gradient for HIV/Po-PAH. Conclusions: Patients with HIV/Po-PAH are younger and have a better exercise capacity than patients with Po-PAH, have a better exercise capacity and hemodynamic profile compared to patients with HIV-PAH, and their prognosis seems to be related to the hepatic disease rather than to HIV infection. The prognosis of patients with Po-PAH and HIV-PAH seems to be related to the underlying disease.
- 12 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (10) , 3425
Open AccessPulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors
Background: Pulmonary arterial hypertension (PAH) may complicate both portal hypertension (Po-PAH) and HIV infection (HIV-PAH). These two conditions, however, frequently coexist in the same patient (HIV/Po-PAH). We evaluated clinical, functional, hemodynamic characteristics and prognostic parameters of these three groups of patients. Methods: We included patients with Po-PAH, HIV-PAH and HIV/Po-PAH referred to a single center. We compared clinical, functional and hemodynamic parameters, severity of liver disease [Child–Turcotte–Pugh (CTP) and Model for End-stage Liver Disease-Na (MELD-Na) scores], CD4 count and highly active antiretroviral therapy (HAART) administration. Prognostic variables were identified through Cox-regression analysis. Results: Patients with Po-PAH (n = 128) were the oldest, patients with HIV-PAH (n = 41) had the worst hemodynamic profile and patients with HIV/Po-PAH (n = 35) had the best exercise capacity. Independent predictors of mortality were age and CTP score for Po-PAH, HAART administration for HIV-PAH, MELD-Na score and hepatic venous-portal gradient for HIV/Po-PAH. Conclusions: Patients with HIV/Po-PAH are younger and have a better exercise capacity than patients with Po-PAH, have a better exercise capacity and hemodynamic profile compared to patients with HIV-PAH, and their prognosis seems to be related to the hepatic disease rather than to HIV infection. The prognosis of patients with Po-PAH and HIV-PAH seems to be related to the underlying disease.
- 1 March 2023
- Published by Il Pensiero Scientifico Editore in Giornale Italiano di Cardiologia
- Vol. 24 (3) , 161-165
Linee guida europee sull’ipertensione polmonare: cosa c’è di nuovo?
- 1 March 2023
- Published by Il Pensiero Scientifico Editore in Giornale Italiano di Cardiologia
- Vol. 24 (3) , 161-165
Linee guida europee sull’ipertensione polmonare: cosa c’è di nuovo?
- 28 June 2022
- Published by Springer Nature
- p. 13-22
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension
- 28 June 2022
- Published by Springer Nature
- p. 13-22
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension
- 28 June 2022
- Published by Springer Nature
- p. 91-99
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension
- 28 June 2022
- Published by Springer Nature
- p. 91-99
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension
- Open Access
- 1 March 2022
- Published by AME Publishing Company in Annals of Cardiothoracic Surgery
- Vol. 11 (2) , 172-174
Long-term outcomes after pulmonary endarterectomy
Article Abstract Long-term outcomes after pulmonary endarterectomy Fabio Dardi, Alessandra Manes, Daniele Guarino, Sofia Martin Suarez, Antonio Loforte, Mariangela Rotunno, Davide Pacini, Nazzareno Galiѐ, Massimiliano Palazzini
- 1 March 2022
- Published by AME Publishing Company in Annals of Cardiothoracic Surgery
- Vol. 11 (2) , 172-174
Open AccessLong-term outcomes after pulmonary endarterectomy
Article Abstract Long-term outcomes after pulmonary endarterectomy Fabio Dardi, Alessandra Manes, Daniele Guarino, Sofia Martin Suarez, Antonio Loforte, Mariangela Rotunno, Davide Pacini, Nazzareno Galiѐ, Massimiliano Palazzini